𝛼SK or Search

ENTITY

Eloxx Pharmaceuticals (ELOX US)

2

Analysis

Health Care • United States

Eloxx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops molecule medicines to treat rare and ultra-rare genetic diseases caused by non-sense mutations. Eloxx Pharmaceuticals serves patients in the United States and Israel.

more

Refresh

Exchange Announcement • 12 Sep 2026 05:28

S-1 | IPO Registration

Exchange Announcement • 12 Aug 2026 05:19

Current Report (Form 8-K | Period ending 2026-08-11)

Exchange Announcement • 11 Aug 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 05 Jun 2026 05:17

S-1/A | IPO Registration (Amendment)

Exchange Announcement • 02 Jun 2026 04:55

S-1/A | IPO Registration (Amendment)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x